Fetal arrhythmias: intrauterine diagnosis, treatment and prognosis

Acta Paediatrica Japonica; Overseas Edition
Y MaenoJ Ishimatu


Fetal echocardiography can provide useful information for the evaluation of fetal arrhythmias. Between 1980 and 1993, 44 fetuses with arrhythmias were diagnosed in utero at 12 and 40 weeks of gestation in Kurume University Hospital. Fetal bradycardia, tachycardia and ectopic beats were revealed in 17, seven and 20 fetuses, respectively, and their clinical features and prognosis were evaluated. In the 17 fetuses with bradycardia, eight were associated with congenital heart defect, and six of these developed to fetal hydrops. Of the 17 fetuses, four died in utero, one was terminated, and six died after birth. The other six cases survived. Three of these had a pacemaker implanted after birth. In the seven fetuses with tachycardia, transplacental anti-arrhythmic drugs were administered in five cases and conversion of the arrhythmia was achieved in four. None of the cases was associated with any congenital heart defect, and none died. Three infants had paroxysmal tachycardia postnatally. In the 20 fetuses with ectopic beats, arrhythmia was observed postnatally in 10, but all of these were resolved within 3 months after birth. Fetal bradycardias carried a poor prognosis in most cases and further studies are required to establish effe...Continue Reading


Jan 1, 1991·British Heart Journal·L D AllanK Priestley
May 1, 1991·Journal of the American College of Cardiology·K G SchmidtJ A Copel
Nov 1, 1987·Pacing and Clinical Electrophysiology : PACE·D ScagliottiK C Pringle
Dec 1, 1987·Acta Paediatrica Japonica; Overseas Edition·H KatoO Toyoda
Dec 1, 1988·British Heart Journal·M V MachadoL D Allan
Jun 1, 1988·The Journal of Pediatrics·T C MartinM M Maurer
Mar 1, 1988·American Journal of Obstetrics and Gynecology·C P Weiner, M I Thompson
Jul 9, 1988·BMJ : British Medical Journal·D J MaxwellL D Allan
Jan 1, 1987·Fetal Therapy·P A StewartE S Sachs
Dec 1, 1986·Journal of the American College of Cardiology·R J CarpenterH T Engelhardt
Feb 1, 1985·Archives of Disease in Childhood·K HirataT Matsunaga
Sep 1, 1983·British Heart Journal·L D AllanM Tynan
Jun 18, 1981·The New England Journal of Medicine·J T HarriganD Korn

❮ Previous
Next ❯


Jul 20, 1999·Current Problems in Pediatrics·C K PhoonM Rutkowski
Jan 5, 2000·Pediatrics International : Official Journal of the Japan Pediatric Society·H Kato
Jan 5, 2000·Pediatrics International : Official Journal of the Japan Pediatric Society·T TsutsumiH Kato

❮ Previous
Next ❯

Related Concepts

Related Feeds


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.